
Sharon Benzeno
@sbenzeno
PhD_BioBusinessist. CCO at @AdaptiveBiotech. Weaving a potpourri of the latest, innovative discoveries that inspire and motivate.
ID: 25297422
19-03-2009 13:55:43
884 Tweet
294 Followers
852 Following





Join Adaptiveās Sharon Benzeno, Jeff Bockman of Lumanity, Axel Hoos of @ScorpionTx, and Asthika Goonewardene of Truist Securities for an #IO360nyc panel on what new and emerging biotechs need to know in the IO biotech space when sourcing investments and partnerships. adaptivebio.tech/kdm




Today CellChemicalBiology published our paper that showcases the key differentiators of Adaptive Biotech's TruAB #antibody discovery platform. This paper features our unique SARS-CoV-2 antibodies, as an example of whatās possible. cell.com/cell-chemical-ā¦



āAll of us in this industry want to make #medicines that help people. Itās good for the industry. Itās good for society.ā ā Daniel Skovronsky Eli Lilly and Company Matthew Herper STAT #STATSUMMIT



āThe really good companies and the really good people do get funded. They have great science. They have line of sight to creating value.ā John Maraganore šŗšøš¬š·šŗš¦š®š± Allison DeAngelis STAT #STATSUMMIT



āBy maximizing the learnings that follow soon after an accelerated approval, we can end up with more treatments that meet full approval standards.ā This approach saved millions of lives and helped get us out of a global pandemic. Peter Kolchinsky

A landmark, breakthrough approval of the 1st gene-edited therapy. Congratulations to Vertex Pharmaceuticals and CRISPR Therapeutics on this tremendous milestone for patients and the field. Endpoints News


When the going gets tough, the tough get going ā Billy Ocean ā¦ā¦Jeb Keiperā© #biotech lifescivc.com/2023/11/darkesā¦

Even (all) great outcomes, like Nimbus, have their challenging moments. Darkest Before Dawn: A Story Of Biotech Optimism In A Tough Market - perspectives from CEO Jeb Keiper lifescivc.com/2023/11/darkesā¦
